期刊文献+

血小板抗原基因分型与配型在血小板输注中的应用 被引量:10

Applications of Platelet Antigen Gene Typing and Matching in the Platelet Transfusion
下载PDF
导出
摘要 本研究建立已知HPA基因型血小板供者库,开展相同HPA基因型血小板交叉配型后输注,防止血小板抗体的产生,解决血小板无效输注。应用PCR-SSP技术对血小板献血者和患者进行HPA基因分型,采集与患者ABO血型及HPA基因型相同血小板制剂,再加以固相凝集法配型相合后输注。结果表明,牡丹江地区HPA血型分布的遗传特征具有本地区人群特点,具有最高杂合度的是HPA-15,其次是HPA-3。采用ABO血型及HPA基因型均相同加固相凝集配型相合血小板输注有效率94.4%。采用ABO血型相同随机血小板固相凝集配型相合输注有效率77.8%。结论:牡丹江地区HPA血型分布的遗传特征具有多态性,采用血小板HPA同基因型供者采集加配型输注可防止血小板免疫性抗体及输注无效的发生,采用ABO同型随机血小板加配型输注是提高血小板输注的效果、防止输注无效发生的既经济又简便的方法。 The aim of this study was to establishment of known HPA genotype platelet donor data base and carry out the platelet antigen gene typing and matching in the platelet transfusion so as to prevent the production of the antibody and to avoid the platelet transfusion refractoriness.HPA of the donors and the patients were genotyped by PCR-SSP.The platelet transfusion with the same ABO type and HPA genotypes as the patient was selected and infused if the solid-phase agglutination matching was consistent.The results showed that the distribution of HPA types in Chinese Mudanjiang area had its own characteristics.HPA-15 had the greatest heterozygosity,and then HPA-3.The effective rate was 94.4% if both the HPA types and the ABO types were coincident while the effective rate was 77.8% when only ABO types were coincident.It is concluded that the distribution of HPA types in Chinese Mudanjiang area presents genetic polymorphism.The platelet transfusion with genetic typing and matching of both HPA and ABO types is an effective way to avoid production of the antibody and platelet transfusion refractoriness.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2014年第1期199-203,共5页 Journal of Experimental Hematology
基金 黑龙江省卫生厅基金项目(2011-594)
关键词 血小板 血小板抗原基因 HPA基因 血小板配型 血小板输注 platelet platelet autigen gene HPA gene platelet matching platelet transfusion
  • 相关文献

参考文献11

二级参考文献49

  • 1刘达庄,包于勤.简易致敏红细胞血小板血清学技术的研究和应用[J].中华血液学杂志,1993,14(12):642-644. 被引量:37
  • 2骆群,刘景汉.输血引起的免疫排斥、耐受与抑制[J].临床输血与检验,2005,7(2):152-154. 被引量:12
  • 3于颖,王志平.血小板输注的相关免疫反应[J].中国误诊学杂志,2005,5(4):648-649. 被引量:2
  • 4Legler TJ,Fischer I,Dittmann J,et al.Frequency and causes of refactoriness in multiply transfused patiens[J].Ann Hematol,1997, 74(4):185- 189.
  • 5MCFARLAND J G, ANDERSON A J, SLICHTERN S I. Factors influencing the transfusion response to HLA - selected apheresis donor platelets in patients refractory to random plateletes in patients refractory to random platelet concen- trates [ J ]. Br Haematol, 1989,73 : 380.
  • 6胡丽华.临床血液检验[M].北京:中国医药科技出版社,2004:118-119,274-275.
  • 7刘竞,李代渝,孟庆宝.输血后紫瘢血小板输注无效[M]//夏琳.临床输血诊疗技术.北京:人民出版社,2008:163-176.
  • 8Davoren A, Mcparland R Crowley J, et al.Antenatal screen- ing for human platelet antigen la:results of a prospective study at alarge maternity hospital in Ireland[J]. B JOG, 2003, 110(5):492-496.
  • 9Novotny VMJ. Prevention and management of platelet transfusion refractoriness[ J]. Vox Sang, 1999, 76( 1 ) : 1
  • 10Haddad SA, Lichtiger B, Klein HG, et al. In vivo efficacy of shipped HLA-matched platelets [ J ]. Transfusion, 2006, 46 ( 8 ) : 1306-1310

共引文献75

同被引文献93

引证文献10

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部